# TRICARE; Coverage of National Cancer Institute (NCI) Sponsored Phase I Studies
> **US Department of Defense** · Final rule. · Published 2011-01-13 · Effective 2011-02-14 · 76 FR 2253
## Document
- **Document number:** 2011-621
- **Category:** personnel
- **Sub-agency:** US Department of Defense
- **Federal Register citation:** 76 FR 2253
- **CFR reference:** 32 CFR 199
- **Publication date:** 2011-01-13
- **Effective date:** 2011-02-14
- **DOD docket:** DoD-2009-HA-0051
## Abstract

This final rule adds coverage of National Cancer Institute (NCI) sponsored Phase I studies for certain beneficiaries. The NCI sponsored clinical treatment trials are conducted in a series of steps called phases. Phase I trials are the first studies conducted in people. They evaluate how a new drug should be given (by mouth, injected into the blood, or injected into the muscle), how often, and what dose is safe.

## Source
- [Federal Register document](https://www.federalregister.gov/documents/2011/01/13/2011-621/tricare-coverage-of-national-cancer-institute-nci-sponsored-phase-i-studies)
---
*AI Analytics · CC0 1.0*